DOX decreases body mass gain over time in a sub-chronic toxicity model. by Gonçalo C. Pereira (156673)

Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

AR1’s occurrence gives rise to a decreased preference of ABP for AR2 and 3. by Li-Dong Huang (5659273)

Nicotine decreases PDI expression in e15 rat placentas. by Michael K. Wong (646399)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

WDR81 is decreased in brains of patients with indicated neurodegenerative diseases compared with brains of control individuals. by Xuezhao Liu (413291)

Expression of human PON1 decreases superoxide levels in <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

Methylation content of mouse liver DNA (% 5-mC). by Ester Alves Mota (8474316)

The protein level of ApoB was decreased in HCV-infected cells. by Bei Wang (116772)

<i>mbtK</i> deletion decreases phospholipid abundance during iron starvation. by Cressida A. Madigan (713924)

AnxA5 results in a tendency to decrease the monocyte endothelium interaction in a flow model. by Robert Stöhr (3583700)

A savanna response to precipitation intensity - Fig 5 by Ryan S. Berry (3913207)

Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC. by Marcus Hollenbach (376231)

“…Co-treatment of LPS and EP indicated significant dose-dependent reduction of LPS-induced markers of inflammation <b>(A1)</b> and fibrosis <b>(B1, C1)</b>. Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”

Anandamide decreases locomotor activity and rearing in small open field. by Adriaan W. Bruijnzeel (2605954)

GSK-3β inhibition or silencing decreases reporter activity. by Rong Guo (50063)

SPARC overexpression promotes AC invasion by decreasing type IV collagen levels in the BM. by Meghan A. Morrissey (2541352)

Α-Difluoromethylornithine (DFMO) treatment decreases lung metastasis of MDA-MB-231 cells by Monica M Richert (63671)

“…<p><b>Copyright information:</b></p><p>Taken from "Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment"</p><p>Breast Cancer Research 2005;7(5):R819-R827.…”

Mutation of conserved V27 or G29 abrogates cleavage of p12. by Florian Simon (5387228)